COYA THERAPEUTICS INC (COYA) Stock Analyst Earnings Estimates
NASDAQ:COYA - Nasdaq - US22407B1089 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.002M | 3.673M -38.81% | 5.738M 56.22% | 5.1M -11.12% | 15.3M 200.00% | 25.5M 66.67% | 31.29M 22.71% | 88.242M 182.01% | 264.71M 199.98% | 458.84M 73.34% | |||
| EBITDA YoY % growth | -4.85M -602.90% | -9.78M -101.65% | -7.333M 25.02% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -4.87M -605.80% | -9.81M -101.44% | -7.36M 24.97% | -18.091M -145.79% | -24.17M -33.61% | -35.7M -47.70% | -15.3M 57.14% | -5.1M 66.67% | -2.433M 52.30% | 50.851M 2,190.31% | 217.09M 326.91% | 403.64M 85.93% | |
| Operating Margin | N/A | N/A | -122.63% | -492.53% | -421.23% | -700.00% | -100.00% | -20.00% | -7.77% | 57.63% | 82.01% | 87.97% | |
| EPS YoY % growth | N/A | N/A | -0.79 57.44% | -1.11 -41.06% | -1.33 -19.22% | -1.34 -0.58% | -0.57 57.25% | -0.19 66.07% | -0.10 47.37% | 1.74 1,810.00% | 7.07 305.26% | 12.37 75.04% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.27 -196.54% | -0.36 -2.00% | -0.29 -52.10% | -0.25 3.23% | -0.46 -71.07% |
| Revenue Q2Q % growth | 68.003K -98.87% | 102K -19.69% | 2.397M -30.02% | 459K | 459K 574.97% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -4.658M -331.93% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.26 45.83% | -0.42 | 0.16 | 38.58% |
| Q2 2024 Q2Q % growth | -0.19 38.71% | -0.14 | -0.05 | -33.05% |
| Q1 2024 Q2Q % growth | -0.35 -25.00% | -0.31 | -0.04 | -14.38% |
| Q4 2023 Q2Q % growth | 0.28 | 0.27 | 0.01 | 5.58% |
| Q3 2023 Q2Q % growth | -0.48 | -0.38 | -0.10 | -27.19% |
| Q2 2023 Q2Q % growth | -0.31 | -0.33 | 0.02 | 5.02% |
| Q1 2023 Q2Q % growth | -0.28 | -0.44 | 0.16 | 36.16% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 178.5K | -178.5K | -100.00% | |
| Q2 2024 Q2Q % growth | 3.425M | 3.978M | -552.73K | -13.89% |
| Q4 2023 Q2Q % growth | 6.002M | 7.65M | -1.648M | -21.54% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -3.25% | 15.87% | -2.42% | 2.89% |
| Revenue | N/A | N/A | 0.93% | 0.69% |